Page 243 - 82_ex2

Surgical treatment of obesity: pros and cons 47 Fried M, Yumuk V, Oppert JM, Scopinaro N, Torres
A, Weiner R et al. Interdisciplinary European
and microvascular complications in moderately to guidelines on metabolic and bariatric surgery. Obes
severely obese patients with type 2 diabetes mellitus. J Surg 2014;24:42-55.
Am Coll Surg 2013;216:545-56; discussion 56-8.
48 Bonomi AG, Westerterp KR. Advances in physical
33 Francisco Martin-Rodriguez J, Cervera-Barajas A, activity monitoring and lifestyle interventions in
Madrazo-Atutxa A, Pablo Garcia-Luna P, Luis Pereira obesity: a review. Int J Obes 2011;36:167-77.
J, Castro-Luque J et al. Effect of bariatric surgery on
microvascular dysfunction associated to metabolic 49 Miller CT, Fraser SF, Levinger I, Straznicky NE,
syndrome: a 12-month prospective study. Int J Obes Dixon JB, Reynolds J et al. The effects of exercise
(Lond) 2014. training in addition to energy restriction on functional
capacities and body composition in obese adults
34 Jackson S, le Roux CW, Docherty NG. Bariatric during weight loss: a systematic review. PLoS ONE
surgery and microvascular complications of type 2 2013;8:e81692.
diabetes mellitus. Curr Atheroscler Rep 2014;16:453.
50 Jensen MD, Ryan DH. New obesity guidelines:
35 Ashrafian H, Ahmed K, Rowland SP, Patel VM, promise and potential. JAMA 2014;311:23-4.
Gooderham NJ, Holmes E et al. Metabolic surgery
and cancer: protective effects of bariatric procedures. 51 Jensen MD, Ryan DH, Apovian CM, Ard JD,
Cancer 2011;117:1788-99. Comuzzie AG, Donato KA et al. 2013
AHA/ACC/TOS guideline for the management of
36 Ashrafian H, le Roux CW, Rowland SP, Ali M, overweight and obesity in adults: a report of the
Cummin AR, Darzi A et al. Metabolic surgery and American College of Cardiology/American Heart
obstructive sleep apnoea: the protective effects of Association Task Force on Practice Guidelines and
bariatric procedures. Thorax 2012;67:442-9. The Obesity Society. J Am Coll Cardiol
2014;63:2985-3023.
37 Hafeez S, Ahmed MH. Bariatric surgery as potential
treatment for nonalcoholic fatty liver disease: a future 52 Apovian CM, Aronne LJ, Bessesen DH, McDonnell
treatment by choice or by chance? J Obes ME, Murad MH, Pagotto U et al. Pharmacological
2013;2013:839275. management of obesity: an endocrine Society clinical
practice guideline. J Clin Endocrinol Metab
38 Pontiroli AE, Benetti A, Folini L, Merlotti C, Frige F. 2015;100:342-62.
Other aspects of bariatric surgery: liver steatosis,
ferritin and cholesterol metabolism. Nutr Hosp 53 Fontana L, Partridge L. Promoting health and
2013;28 Suppl 2:104-8. longevity through diet: from model organisms to
humans. Cell 2015;161:106-18.
39 Maestro A, Rigla M, Caixas A. Does bariatric surgery
reduce cancer risk? A review of the literature. 54 Bray GA, Frühbeck G, Ryan DH, Wilding JP.
Endocrinol Nutr 2015;62:138-43. Management of obesity. Lancet 2016.

40 Rubino F, Cummings DE. Surgery: The coming of 55 Cleveland Clinic. Bariatric weight loss surgery.
age of metabolic surgery. Nat Rev Endocrinol Weight loss options.
2012;8:702-4. clevelandclinic.org/services/bariatric-and-metabolic-
institute
41 Rubino F, Shukla A, Pomp A, Moreira M, Ahn SM,
Dakin G. Bariatric, metabolic, and diabetes surgery: 233
what's in a name? Ann Surg 2014;259:117-22.

42 Rubino F, Nathan DM, Eckel RH, Schauer PR,
Alberti KG, Zimmet PZ et al. Metabolic surgery in the
treatment algorithm for type 2 diabetes: a joint
statement by international diabetes organizations.
Diabetes Care 2016;39:861-77.

43 Cefalu WT, Rubino F, Cummings DE. Metabolic
surgery for type 2 diabetes: changing the landscape of
diabetes care. Diabetes Care 2016;39:857-60.

44 vBuchwald H, Buchwald JN. Evolution of operative
procedures for the management of morbid obesity
1950-2000. Obes Surg 2002;12:705-17.

45 Ashrafian H, Bueter M, Ahmed K, Suliman A, Bloom
SR, Darzi A et al. Metabolic surgery: an evolution
through bariatric animal models. Obes Rev
2010;11:907-20.

46 Rubino F, Schauer PR, Kaplan LM, Cummings DE.
Metabolic surgery to treat type 2 diabetes: clinical
outcomes and mechanisms of action. Annu Rev Med
2010;61:393-411.

@Real Academia Nacional de Farmacia. Spain